newsfilter
← Latest News
ACCESS Newswire·

Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds

SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 23, 2025 / Ensysce Biosciences, Inc. , a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief